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Abstract
Introduction and hypothesis The purpose of this study is to
identify risk factors for mesh erosion in women undergoing
minimally invasive sacrocolpopexy (MISC). We hypothesize
that erosion is higher in subjects undergoing concomitant
hysterectomy.
Methods This is a retrospective cohort study of women who
underwentMISCbetweenNovember2004andJanuary2009.
Demographics, operative techniques, and outcomes were
abstracted from medical records. Multivariable regression
identified odds of erosion.
Results Of 188 MISC procedures 19(10%) had erosions.
Erosion was higher in those with total vaginal hysterectomy
(TVH) compared to both post-hysterectomy (23% vs. 5%,
p=0.003) and supracervical hysterectomy (SCH) (23% vs.
5%, p=0.109) groups. In multivariable regression, the odds
of erosion for TVH was 5.67 (95% CI: 1.88–17.10)
compared to post-hysterectomy. Smoking, the use of
collagen-coated mesh, transvaginal dissection, and mesh
attachment transvaginally were no longer significant in the
multivariable regression model.
Conclusion Based on this study, surgeons should consider
supracervical hysterectomy over total vaginal hysterectomy
as the procedure of choice in association with MISC unless
removal of the cervix is otherwise indicated.
Keywords Erosion.Mesh.Hysterectomy.Laparoscopy.
Sacrocolpopexy
Introduction
Rates of recurrent prolapse after traditional vaginal repairs
have been documented as high as 58% [1] with reoperation
rates up to 30% [2]. The use of synthetic mesh to augment
reconstructive procedures has gained popularity over the
years in an effort to reduce recurrence. Despite recent
trends toward vaginal placement of mesh, mesh has been
traditionally used abdominally to correct apical prolapse of
the vaginal vault [3]. Sacrocolpopexy was first described
by Arthure [4] in 1957 and understanding of this procedure
has evolved over the past five decades. A recent compre-
hensive review of sacrocolpopexy describes the reoperation
rate for prolapse of only 2.2% [5]. Minimally invasive
sacrocolpopexy (MISC) has been introduced in an effort to
decrease pain, reduce recovery, and improve cosmetic
results by eliminating the need for a large abdominal incision
[6]. The robotic-assisted laparoscopic sacrocolpopexy
(RALSC) and conventional laparoscopic sacrocolpopexy
(LSC) have shown similar medium-term efficacy to tradi-
tional open approaches with less pain, less blood loss,
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the purposes of this study, the term MISC refers to both the
RALSC and LSC.
One complication unique to the use of synthetic mesh is
its tendency to erode through adjacent tissue. Erosions are
usually defined as visible portions of surgical material,
usually mesh or suture, which has become exposed through
the epithelium of the vagina or into adjacent visceral
organs. Mesh erosion rates with sacrocolpopexy range from
2% to 10% in the literature [5, 10–12]. The consequences
of erosions range from negligible to severe.
Modifiable risk factors associated with mesh erosions
include smoking [10], concomitant hysterectomy [10],
mesh type [13], and placement of mesh transvaginally
[14]. The majority of studies assessing mesh erosion have
been performed on traditional abdominal sacrocolpopexy
(ASC). MISC are performed with a slightly different tech-
nique and thus has potentially different risks of erosion. The
purpose of this study was to identify rates and risk factors for
mesh erosion in women undergoing MISC using various
techniques. It is our hypothesis that the mesh erosion rate is
higher in subjects undergoing concomitant hysterectomy
compared to those women who are post-hysterectomy.
Materials and methods
This was an IRB-approved, retrospective cohort study of
women who underwent MISC using one of two techniques
(RALSC or LSC) between November 2004 and January
2009. Surgeries were performed at two institutions respon-
sible for training in the UCSD/Kaiser Permanente San
Diego Female Pelvic Medicine and Reconstructive Surgery
Fellowship program. Subjects were excluded if they did not
have a follow-up postoperative physical examination.
Data was extracted from the electronic medical record
and hospital charts. Age, race, gravity, parity, history of
diabetes mellitus, smoking, and hormone status along with
physical examination including weight and pelvic organ
prolapse quantification (POP-Q) [15], was also collected.
Operative techniques, complications, blood loss, concomi-
tant procedures, and operative times were abstracted from
the hospital records. Postoperative follow-up visits includ-
ing POP-Q and the detection of a mesh erosion were also
documented.
Operative techniques
The RALSC technique was performed exclusively at
UCSD by two attending surgeons. If a hysterectomy was
indicated, a laparoscopic supracervical hysterectomy (SCH)
was performed in a routine fashion with the uterine corpus
removed using a morcellator. The da Vinci robot-S (Intuitive
Surgical Inc., Sunnyvale, CA) was docked to three of the
operative ports and a camera port. The vesicovaginal,
rectovaginal, and presacral spaces were all dissected with
robotic assistance. The vaginal dissections were performed
with the assistance of a vaginal probe to delineate the planes
of dissection. In all cases, a non-coated type 1 monofilament
polypropylene meshwas attachedtothe anteriorand posterior
vaginal walls (and cervical stump if applicable) with a
minimum of four monofilament permanent sutures to each
vaginal wall. Two permanent sutures were placed at the level
of the sacral promontory to secure the mesh to the anterior
longitudinal ligament. The peritoneum was then reapproxi-
mated over the mesh with absorbable suture.
The LSC technique was performed exclusively at Kaiser
Permanente by four attending surgeons using three tech-
niques: (1) entire procedure performed laparoscopically for
the subjects who were post-hysterectomy, (2) total vaginal
hysterectomy (TVH) with mesh attachment transvaginally
prior to laparoscopic portion of the procedure (vaginally
assisted laparoscopic sacrocolpopexy (VALSC)), and (3)
TVH followed by mesh attachment laparoscopically after
vaginal closure of the cuff (vaginal hysterectomy prior to
laparoscopic sacrocolpopexy (VHLSC)). One of the two
types of mesh were used for each procedure; a type 1
monofilament polypropylene mesh coated with a hydrophilic
porcine collagen (Pelvitex, Bard, Covington, GA) or non-
coated type 1 monofilament polypropylene. For the laparo-
scopic portion of each case, a total of four to five ports were
placed. For subjects who were post-hysterectomy prior to this
procedure,thespacesweredissectedlaparoscopicallywiththe
use of a vaginal probe. Laparoscopicattachmentof mesh took
place using a minimum of four polypropylene monofilament
sutures to each wall. If a hysterectomy was indicated, a total
vaginal hysterectomy was performed followed by trans-
vaginal development and dissection of the anterior and
posterior vaginal planes in most cases. For the VALSC group,
mesh was attached transvaginally to the anterior and posterior
vaginal surfaces with at least four polypropylene monofila-
ment sutures. The tails of the mesh were then placed into the
intraperitoneal cavity followed by transvaginal closure of the
cuff. The laparoscopic attachment of the mesh to the anterior
longitudinal ligament followed. Alternatively, the VHLSC
group underwent TVH and dissection followed by closure of
the vaginal cuff. Mesh placement and attachment was then
performed laparoscopically.
For all LSC cases, the proximal tails of the mesh were
attached to the anterior longitudinal ligament at the level of
the sacral promontory using two to four titanium sutures
(Protack; Tyco Healthcare, Norwalk, CT) or interrupted
monofilament permanent suture. The peritoneum was
reapproximated over the mesh with absorbable suture.
For all MISC, concomitant repairs such as anterior repairs,
posterior repairs, or mid-urethral slings were performed either
206 Int Urogynecol J (2011) 22:205–212prior to the sacrocolpopexy or after. The variations in
technique for all procedures or the type of mesh used were
based on surgeon preference.
All included subjects were evaluated postoperatively at
standard intervals. They had a POP-Q examination, vaginal
inspection with a clear plastic speculum, and digital rectal
examination to evaluate prolapse status and presence of
mesh erosion. Our primary outcome of erosion was
identified if any mesh or permanent suture material was
seen in the vagina or other adjacent tissues.
Chi-square and Fisher exact tests were used to compare
categorical variables and compare erosion rates between
various groups. The Mann Whitney U and Wilcoxon's rank
tests were used to compare non-parametric data and explore
variables which may represent risk factors for mesh
erosion. Multivariable logistic regression was used to
assess independent predictors for mesh erosion while
controlling for potential confounders. Variables were
included if they had a p value<0.10 on univariate analysis.
Odd ratios (OR) and 95% confidence intervals (CI) are
reported. A p value of <0.05 was considered statistically
significant. Statistical analysis was performed with PASW
18 (SPSS, Inc, Chicago, IL).
Based on a study of ASC by Thompson et al., subjects
who had previous hysterectomy had a mesh erosion rate of
0.7%, while those who underwent concomitant total
abdominal hysterectomy had an erosion rate of 13.6%
[16]. We based our power analysis on this data which
indicated that 50 subjects would be required in each group
in order to detect a difference in mesh erosion rate of 1% to
14% with α=0.05 and 80% power.
Results
A total of 196 women underwent MISC and 96% had
sufficient data for follow-up. The mean age of the 188
women was 61±9 years and median prolapse stage was 3
(2–4). Median follow-up was 20 weeks (3–124 weeks) in
the RALSC compared to 14 weeks (2–171 weeks) for LSC
group (p =0.280). All 21 women with concomitant SCH
had RALSC and all 57 women with concomitant TVH had
LSC. Of those who had a TVH, 29 had the mesh attached
to the vagina transvaginally (VALSC) while 28 had the
mesh attached laparoscopically (VHLSC). The overall
mesh erosion rate was 10% (19/188). Mesh erosion rates
were 5% in both the post-hysterectomy and SCH groups
(p=0.984). In the concomitant TVH group, mesh erosion
rates were 23% (p=0.003). A subanalysis was performed
on the subjects with TVH who were divided into VALSC
and VHLSC. VHLSC had a higher erosion rate than
VALSC, although this difference was not statistically
significant (Fig. 1).
Of the 19 erosions, 1 involved suture only, 15 involved
exposed mesh at the level of the apex, 1 occurred along
the anterior wall, 1 resulted in a vesicovaginal fistula and
1 erosion was into the bladder without fistula. There
were no erosions noted at the level of a mid-urethral
Fig. 1 Mesh erosion rates in
women undergoing minimally
invasive sacrocolpopexy (MISC)
using various techniques. PH
post-hysterectomy (reference
group), SCH supracervical
hysterectomy, TVH total
vaginal hysterectomy, VALSC
vaginally assisted laparoscopic
sacrocolpopexy (transvaginal
placement of mesh), and VHLSC
vaginal hysterectomy prior to
laparoscopic sacrocolpopexy
(laparoscopic placement
of mesh). Asterisk Fisher's
exact test
Int Urogynecol J (2011) 22:205–212 207sling or along the posterior wall of the vagina. The mean
time to mesh erosion detection was 23±21 weeks (range
3–86 weeks) with a median of 14 weeks (all 19 subjects).
There was only one subject in the SCH group with mesh
erosion which occurred at 6 week. The mean time to erosion
for the post-hysterectomy subjects were 31±29 weeks
(median 27, n=5) and 21±17 weeks (median 12, n=13) for
the TVH subjects, this difference did not meet statistical
significance (p=0.661).
There were no differences between subjects who did and
did not develop mesh erosion except for concurrent
posterior colporrhaphy and hysterectomy (p<0.1(Table 1)).
Multivariable regression revealed that only concurrent
TVH remained a significant contributor to mesh erosion
(Table 2). Concurrent TVH was performed in 30% (57/188)
of subjects and was associated with a nearly sixfold
increase in erosion compared to post-hysterectomy. The
odds of mesh erosion with supracervical hysterectomy were
equal to post-hysterectomy.
A subanalysis was performed using three variables
potentially increasing the risk of mesh erosion in subjects
undergoing TVH. A multivariate logistic regression model
was performed on the (1) utilization of transvaginaldissection
(n=53), (2) use of a collagen-coated polypropylene mesh
(n=46) and (3) attachment of mesh transvaginally (VALSC,
n=29) or laparoscopically (VHLSC, n=28) and (4) attending
surgeon. None of these variables were found to be significant
to the contribution of mesh erosion (data not shown). There
was a trend towards increased mesh erosion with mesh
placed laparoscopically as opposed to transvaginally (OR
2.96; 95%CI: 0.78–11.3) although this finding was not
statistically significant.
Variable No mesh erosion(n=169) Mesh erosion(n=19) p value
Age (years) 60.7±9.2 61.4±5.9 0.707
a
Gravity 3.4 (3) 2.8 (3) 0.940
b
Para 2.9 (3) 2.5 (3) 0.695
b
Weight (lbs) 155.2±24.8 147.2±24.8 0.245
a
Race 0.912
c
White 80% 74%
Hispanic 15% 21%
Asian 4% 5%
AA 1% 0%
Other 1% 0%
Diabetes mellitus 9% 16% 0.401
d
Smoking 0.341
c
Current 4% 5%
Past 18% 32%
HRT/menopause 0.394
c
Premenopausal 17% 5%
Menopause+HRT 27% 26%
Menopause no HRT 56% 68%
Preop Ba 2.9 (3) 2.9 (3) 0.391
b
Preop C 1.0 (1) 0.4 (0) 0.562
b
Preop Bp 0.1 (−1) −0.05 (0) 0.387
b
Prolapse stage 2.8 (3) 2.9 (3) 0.558
b
Postop Hgb 10.9±1.2 10.9±0.8 0.901
a
Surgery time (min) 255.7±71.0 262.3±67.8 0.512
a
Anterior repair 2% 5% 0.349
d
Paravaginal repair 9% 16% 0.401
d
Posterior repair 15% 32% 0.075
c
Mid-urethral sling 46% 47% 0.920
c
Hysterectomy status 0.001
c
Post-hysterectomy 62% (5/19) 26%
SCH 12% (1/19) 5%
TVH 26% (13/19) 68%
Table 1 Univariate analysis
of demographics, baseline
characteristics, and concomitant
procedures
HRT Hormone replacement
therapy—systemic, Hgb
Hemoglobin SCH Supracervical
hysterectomy, TVH Total
vaginal hysterectomy
aContinuous data summarized as
mean ± SD and compared between
groups with the use of Mann–
Whitney U test(<30 cases, central
limit theorem)
bNon-parametric continuous data
summarized as mean (median) and
compared with the use of the
Wilcoxon's rank test
cCategorical data summarized as
frequency (%) and compared
between groups with the use of
the Χ
2 test
dFisher's Exact test
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estrogen. Only three (20%) resolved with estrogen therapy.
A total of 10 (53%) required additional surgical procedures
while five (26%) opted for expectant management (Fig. 2).
The decision to proceed with surgical management was
based on subject's preference, symptoms, or the severity of
the mesh erosion. Subject no. 1 had transvaginal resection
of exposed mesh with repair of incidental cystotomy which
occurred on the posterior bladder wall at the time of mesh
resection. Subject no. 2 had a vesicovaginal fistula with
erosion above the trigone, which was repaired after two
separate procedures, the second procedure included a
laparotomy with omental J-flap. Subject no. 3 had a suture
excised transvesically at the time of initial operation, she
subsequently developed <1 cm portion of mesh in her
bladder and declined surgical excision. She has been
expectantly managed with periodic cystoscopy since March
2007 and continues to have a stable erosion without
evidence of inflammation or recurrent infections.
Discussion
Mesh erosion associated with pelvic reconstructive surgery
is a recognized complication of using synthetic mesh.
Erosions may be asymptomatic and inconsequential or they
may present with severe infection or result in fistulae.
Identification of modifiable risk factors for the development
of this complication is critical. Our study demonstrates a
s i x f o l di n c r e a s er i s ko fm e s he r o s i o nw h e nT V Hi s
performed at the time of MISC compared to subjects who
had MISC post-hysterectomy or with SCH. After careful
analysis of all potentially contributing variables, only the
TVH remained a significant modifiable risk factor. Only
20% of those with erosions responded to conservative
estrogen therapy alone.
Our findings are supported by studies of total abdominal
hysterectomy (TAH) and open ASC. Cundiff et al. found
that TAH at the time of ASC resulted in a rate of erosion of
14%, which was a fivefold increase risk over subjects who
had ASC without hysterectomy [10]. Bensinger et al. showed
a sevenfold increase risk of mesh erosion with subjects who
had a TAH at the time of their ASC compared with subjects
who underwent SCH at the time of ASC [17]. Despite
differences in operative techniques for MISC, there
appears to be comparable erosion rates. Our study is
the first to compare erosions in MISC in a large cohort
of women.
Mesh erosion may result from a combination of bacterial
infection and devascularization of the vaginal cuff. Opening
of the vaginal cuff with exposure of the surgical bed to
vaginal flora may be a key component in the evolution of
subsequent erosion. Our reported mesh erosion rate of 23%
for subjects who had concomitant TVH with MISC is
Variable Exp (B) odds ratio 95% CI for Exp (B) p value
Constant 0.043
Posterior repair 1.88 0.62–5.70 0.268
Ref
a=Post-hysterectomy
SCH 0.99 0.11–9.03 0.996
TVH 5.67 1.88–17.10 0.002
Table 2 Multivariable logistic
regression model for posterior
repair and type of hysterectomy
aReference group
SCH supracervical hysterectomy,
TVH total vaginal hysterectomy
Fig. 2 Only 3 (20%) of the 15
erosions resolved with estrogen
therapy alone. A total of 10
(53%) of the 19 erosions
required surgical management
for definitive treatment and all
10 of these erosions resolved
after surgery. Of the 19 subjects,
five (3+2; 26%) ultimately
opted for expectant management
without further follow-up at the
time of this review
Int Urogynecol J (2011) 22:205–212 209higher than rates reported in the literature for TAH with
ASC. Our erosion rates were also significantly higher than
those reported by a large retrospective study in which
laparoscopic-assisted vaginal hysterectomies (LAVH) were
performed with laparoscopic sacrocolpopexy [18]. There
are several possible explanations for this finding. TVH
inherently differs from TAH, TLH, and even LAVH in the
amount of surgical bed exposure to vaginal flora which
may result in higher risk of infection. This is supported by
the observation that subjects who underwent a supracervical
hysterectomy at the time of their sacrocolpopexy had the
same rate of erosion as the post-hysterectomy group. Our
overall rates of mesh erosion for post-hysterectomy subjects
(5%) and those with concomitant SCH (5%) are consistent
with the current literature [10, 19]. This finding supports
the adoption of SCH over TVH when a hysterectomy
is indicated unless removal of the cervix is clinically
necessary. However, while SCH may be associated with
lower erosion rates, there may be other consequences
such as cervical elongation, subsequent development of
dysplasia, or bleeding problems that should be balanced
against the risk of erosion.
The recent introduction of minimally invasive techniques
has improved recovery times, decreased length of hospital
stay, decreased intraoperative blood loss, improved post-
operative pain, and reduced time to resume normal activity
[9, 20–23]. Unfortunately, these techniques tend to take
longer to perform [9, 24]. Surgeons continue to modify their
techniques in order to decrease operative time which
decreases operative morbidity. Large retrospective studies
demonstrated low mesh erosion rates with LAVH and
transvaginal cuff closure (2.3%) which prompted our
institution to develop the VALSC and VHLSC technique to
reduce surgical duration [18]. Combined abdominal–vaginal
procedures have been previously described. One small study
reported a 40% mesh erosion rate but included only five
cases [14] while a larger retrospective study of 169 patients
who underwent abdominovaginal sacral colpoperineopexy
had a documented mesh erosion rate of 6.5% with a median
time to erosion of 3 months [25]. A subanalysis of our data
revealed that concomitant TVH was the single contributing
factor for mesh erosion, not the performance of transvaginal
dissections. In addition, contrary to what was expected, we
found an increased risk of erosion when the mesh was
placed laparoscopically as opposed to transvaginally after
TVH, but this difference was not statistically significant.
It has been documented that mesh properties play a role
in the relative risk of developing mesh erosion. Collagen-
coated polypropylene mesh was used at our institution after
several reports indicated prevention of erosion by position-
ing a collagen barrier between the synthetic mesh and
vaginal mucosa. One study included 29 subjects and no
mesh erosions were observed over a 2-year period [26].
However, this study was conducted in post-hysterectomy
subjects only and therefore did not result in any inoculation
of the collagen-coated mesh with vaginal flora. In vivo
animal studies have observed slightly higher levels of acute
inflammation with the collagen-coated mesh when com-
pared to non-coated mesh [27]. Another study confirmed
the colonization of collagen-coated mesh with greater than
14 different types of bacteria when placed vaginally [28].
Although we did not find a statistically significant difference
in mesh erosion between the collagen-coated and non-coated
material there was a trend towards increased erosion in the
collagen-coated group (OR: 3.53; 95%CI:0.40–31.4).
The mesh erosions in our cohort were managed both
conservatively and surgically. For 20% of our subjects,
estrogen alone was sufficient to resolve their mesh erosion
which is similar to other reports of 18.5% of cases treated
successfully with vaginal estrogen or antibiotic cream [29].
One subject was treated successfully with office excision.
In 47% of our subjects, conservative management or office
resections were unsuccessful and they chose to return to
the operating room for a mesh excision. There were no
recurrences of erosion after surgical excision. The remain-
ing 32% either had persistent erosions which were
asymptomatic and declined further treatment or they did
not have further follow-up. Cundiff et al. reported in their
study that 13 of 17 mesh erosions required at least one
surgical intervention [10]. Other studies have shown that
definitive surgical excision was ultimately required in
80–100% of cases [14, 29]. In our study, a total of seven
subjects had some form of bladder integrity compromise at
the time of their LSC; two of these subjects went on to have
mesh erosions involving the bladder. This suggests that the
usage of mesh should be minimized in areas where bladder
disruption has occurred intraoperatively.
Limitations of this study are primarily related to its
retrospective nature. We found a statistically significant
increased risk of mesh erosion with TVH, but our relatively
small sample size results in a wide confidence interval
which may impact the clinical relevance of this finding.
Our study was likely underpowered to detect a difference
between transvaginal dissections of the planes, the usage of
collagen-coated mesh, or the approach of mesh placement.
This study took place at two institutions with six different
surgeons performing different procedures. Neither of the
institutions performed total laparoscopic hysterectomies at
the time of sacrocolpopexy which limits the ability of this
study to make conclusions with regard to this technique of
minimally invasive hysterectomy. Follow-up intervals were
not standard between all subjects, so it is possible that with
time, the mesh erosion rates would gradually increase and
certain risk factors which were not found to be significant
would actually be associated with mesh erosion if the study
was prolonged. In some cases our follow-up duration was
210 Int Urogynecol J (2011) 22:205–212relatively short making it conceivable that the mesh erosion
rate is actually underestimated in this population. The
retrospective nature of this study made it difficult to assess
subjective symptoms of mesh erosion or resolution there-
fore we only reported on our objective findings. We also
did not assess or report on any data related to sexual
dysfunction, urinary incontinence, defecatory dysfunction,
or pain. We also did not find a significant relationship
between mesh erosion and smoking as has been reported in
other studies [10, 29]. This is likely due to the small
number of subjects who gave a positive history of smoking
(<4%). Our primary objective was to assess the prevalence
and risk factors associated with mesh erosion. The strengths
of this study include the evaluation of two types of MISC
and the inclusion of both TVH and SCH. Additionally,
because of the nature of the UCSD and Kaiser Permanente
Health Care systems, we are confident that subjects who
develop erosions would return to our institutions for
management.
In conclusion, post-hysterectomy MISC and MISC asso-
ciated with concomitant SCH have acceptably low rates of
mesh erosions. However concomitant TVH at the time of
MISC results in a high rate of mesh erosion with a sixfold
increased risk. Based on these data surgeons should consider
SCH as the procedure of choice in association with MISC
unless removal of the cervix is otherwise indicated.
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